Garvin v. Bode Technology & LabCorp — Dismissed Without Prejudice in 43 Days
Alex Garvin asserted two cursor-modification patents — US5995102A and US6118449A — against Bode Technology and Laboratory Corp of America Holdings in the Virginia Eastern District Court. Defendants' motion to dismiss was granted in full, ending the case without prejudice just 43 days after filing.
Cursor-modification patent suit ends at pleading stage in Virginia Eastern District
On 4 October 2023, Alex Garvin filed an infringement action in the Virginia Eastern District Court against Bode Technology and Laboratory Corp of America Holdings (LabCorp), asserting two patents — US5995102A and US6118449A — covering cursor modification technology allegedly embodied in the CDW.com interactive website. Garvin appeared to be acting as plaintiff agent, represented by the law firm listed as '5 Chemin du Kaerlisweg', while defendants were represented by Krystal Brunner Swendsboe of Wiley Rein LLP.
Defendants filed a motion to dismiss (docketed at Nos. 13 and 16), which the court granted in full. The recorded basis of termination is 'Dismissed without Prejudice'; the docket order states that the complaint 'be and is DISMISSED WITHOUT PREJUDICE'. Because the dismissal is without prejudice, Garvin retains the technical ability to refile, subject to any applicable procedural or substantive bars. The specific grounds on which the court granted the motion are not disclosed in the available record excerpt.
The case closed on 16 November 2023 — only 43 days after filing — suggesting the complaint did not survive initial pleading scrutiny. What drove the rapid dismissal (e.g., jurisdiction, standing, pleading deficiency, or subject-matter eligibility) is not disclosed in the available record. Whether Garvin intends to refile with an amended complaint is likewise unknown from the public record.
See Complete Case & Patent Analysis →Filing to Dismissed without Prejudice in 43 days
Case resolved in 43 days — well below median district court patent litigation timelines
US5995102A & US6118449A — cursor modification technology for interactive websites


Any company developing or operating interactive web interfaces that incorporate cursor-modification functionality should consider a freedom-to-operate assessment against US5995102A and US6118449A. The without-prejudice dismissal in this case means both patents remain active enforcement tools. This is particularly relevant for e-commerce platforms, SaaS operators, and digital product teams building interactive UI features.
Official order — verbatim text
The court's order granting defendants' motion to dismiss and dismissing the complaint without prejudice indicates the action did not survive pleading-stage scrutiny. The without-prejudice designation leaves the door open for Garvin to refile; however, the specific grounds for dismissal — which would govern any amended complaint — are not disclosed in the available record excerpt.
Dismissed without prejudice: what the ruling means for both parties
Motion to dismiss granted — complaint failed at pleading stage
The court granted defendants' motion to dismiss (Dkt. Nos. 13 and 16), terminating the case before any merits adjudication. A dismissal without prejudice means the court did not issue a final judgment on the patent claims themselves. The specific grounds for dismissal are not disclosed in the available record.
Pre-merits dismissalWithout prejudice: Garvin may refile, but the path is not clear
A dismissal without prejudice does not bar the plaintiff from refiling the action. However, it does not guarantee a second complaint will succeed — the same deficiencies that led to this dismissal would need to be addressed. Whether the dismissal was with or without prejudice is confirmed: the order and the recorded basis both state without prejudice. The specific terms or conditions, if any, are not in the available record.
Refile option preservedBode Technology and LabCorp exit — but without finality on the patents
Both defendants secured dismissal of the complaint at the pleading stage without needing to litigate infringement or validity. However, because the dismissal is without prejudice, the patents in suit — US5995102A and US6118449A — were not adjudicated invalid or non-infringed. Defendants remain exposed to a potential refiled action on the same patents.
No merits ruling on patentsCursor-modification patent risk remains live for interactive web platforms
Because the court did not rule on infringement or validity, US5995102A and US6118449A remain nominally enforceable. Companies operating interactive web interfaces incorporating cursor-modification functionality — particularly those named in the original complaint — should monitor for any refiled action. The CDW.com interactive website was identified as the accused product in this case.
Patent enforceability unresolvedFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Alex Garvin | Individual | /Search in Eureka ↗ |
| Defendant | Bode Technology | Individual | /Search in Eureka ↗ |
| Co-Defendant | Laboratory Corp Of America Holdings (Lab Corp) | Company | Search in Eureka ↗ |
| Plaintiff counsel | Alex Garvin | Attorney | Counsel for Alex GarvinSearch in Eureka ↗ |
| Plaintiff law firm | 5 Chemin du Kaerlisweg | Law Firm | Representing Alex GarvinSearch in Eureka ↗ |
| Defendant counsel | Krystal Brunner Swendsboe | Attorney | Counsel for Bode TechnologySearch in Eureka ↗ |
| Defendant law firm | Wiley Rein LLP | Law Firm | Representing Bode TechnologySearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Virginia Eastern District CourtSearch in Eureka ↗ |
R&D signals in cursor modification and web interface IP
Forward-looking patent intelligence on cursor modification technology, the asserted portfolios of Garvin, Bode Technology, and LabCorp, and adjacent interactive UI innovation trends.
Garvin's cursor-modification patent family: what else is in scope?
US5995102A and US6118449A are the two asserted patents, both tied to late-1990s application filings. Tracking whether continuation, divisional, or related family patents remain active — and whether new assignments have been recorded — can reveal the full enforcement perimeter of this portfolio and flag additional exposure for web-platform operators.
Portfolio scopeFiling trends in cursor and interactive UI patent technology
The late-1990s saw a wave of software UI patent filings covering cursor behaviour and interactive web elements. Mapping current filing activity in this space — including newer CPC classes for web UI and pointer-event handling — can identify which technology areas remain crowded and where white space exists for modern interactive interface R&D.
Filing trendBode Technology and LabCorp: patent activity in digital diagnostics
Bode Technology and Laboratory Corp of America Holdings operate primarily in forensic DNA and clinical diagnostics. Assessing their patent portfolios in digital-platform and web-interface technology — and any defensive filings they may hold — provides context for how they might respond to a refiled cursor-technology action or adjacent UI-related claims.
Defensive IPAdjacent R&D opportunity: modern pointer and gesture-UI patents
The cursor-modification domain has evolved from simple pointer styling into gesture recognition, haptic feedback, and multi-touch event handling. Late-1990s patents like US5995102A and US6118449A are unlikely to cover these newer modalities, suggesting potential white space for R&D teams working on next-generation interactive UI and pointer-event systems.
White spaceSimilar patent infringement cases involving cursor and web interface technology
Explore related patent infringement actions involving cursor modification and interactive web interface technology filed in US district courts, including the Virginia Eastern District.
Related patent case — similar technology
Comparable case in the same technology domain. Patent holder and defendant reached resolution after proceedings.
SettledRelated infringement action — same court
Comparable The CDW.com interactive website (the cursor modification technology)-adjacent infringement action. Patent enforcement dynamics analysed in depth.
Active · District CourtRelated invalidity challenge — appellate outcome
Combined invalidity and infringement action in the same technology space. Decided after substantive proceedings.
DecidedAlex Garvin's broader IP enforcement history
Alex Garvin's full litigation history covering prior enforcement, licensing activity, and inter partes review proceedings.
Portfolio viewWhat this case signals for cursor-modification and web interface IP
A rapid pre-merits dismissal leaves patent validity unresolved, keeping enforcement risk alive for web-interface operators.
Pre-merits dismissal does not extinguish the patent — monitor for refile
The without-prejudice dismissal means US5995102A and US6118449A were never adjudicated invalid. Any company operating cursor-modification or interactive web-interface technology should track Garvin's filing activity for a potential amended or refiled complaint.
Defendants avoided merits exposure but lack a validity shield
Bode Technology and LabCorp escaped this action at the pleading stage, but neither patent was declared invalid or not infringed. Without an IPR petition or declaratory judgment, both defendants remain exposed to future infringement claims on the same patents.
US5995102A and US6118449A: assessing § 101 and prior-art vulnerability
Cursor-modification patents filed in the late 1990s may face elevated subject-matter eligibility risk under Alice/Mayo. A targeted § 101 and prior-art analysis of both patents could reveal invalidity arguments that would definitively resolve exposure — information not resolved by this dismissal.
Plaintiff's standing and entity status: key questions for any refile
The complaint was filed by an individual plaintiff without a clearly identified corporate assignee on the face of the record. If the motion to dismiss succeeded on standing or ownership grounds, any refile would require Garvin to establish clear chain of title to both patents. Chain-of-title analysis via PatSnap could identify current ownership.
Garvin v Bode — key questions answered
The Virginia Eastern District Court granted defendants' motion to dismiss and dismissed the complaint without prejudice on 16 November 2023, 43 days after filing. No merits ruling on the asserted patents US5995102A or US6118449A was issued.
Alex Garvin asserted two patents: US5995102A (application no. US08/882580) and US6118449A (application no. US09/400038), both relating to cursor modification technology. The accused product identified in the complaint was the CDW.com interactive website.
A dismissal without prejudice means the court did not rule on infringement or validity. The patents remain nominally enforceable and Garvin retains the ability to refile a new or amended complaint. The specific grounds for dismissal are not disclosed in the available public record.
The defendants were Bode Technology and Laboratory Corp of America Holdings (LabCorp). They were represented by Krystal Brunner Swendsboe of Wiley Rein LLP. Plaintiff Alex Garvin was listed as his own plaintiff agent, with '5 Chemin du Kaerlisweg' recorded as the plaintiff law firm.
The case was resolved in 43 days, which is consistent with a successful pleading-stage motion to dismiss. The defendants filed a motion to dismiss (Dkt. Nos. 13 and 16) that the court granted in full. The specific grounds — such as standing, jurisdiction, or pleading deficiency — are not disclosed in the available record.
Track cursor-modification patent risk for your web platform
US5995102A and US6118449A remain enforceable following this without-prejudice dismissal. Run an FTO search and set monitoring alerts in PatSnap Eureka to stay ahead of any refiled action.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.